Bvf Inc 89bio, Inc. Transaction History
Bvf Inc
- $3.27 Billion
- Q2 2024
A detailed history of Bvf Inc transactions in 89bio, Inc. stock. As of the latest transaction made, Bvf Inc holds 7,568,479 shares of ETNB stock, worth $75.5 Million. This represents 1.85% of its overall portfolio holdings.
Number of Shares
7,568,479
Previous 4,047,354
87.0%
Holding current value
$75.5 Million
Previous $47.1 Million
28.68%
% of portfolio
1.85%
Previous 1.41%
Shares
5 transactions
Others Institutions Holding ETNB
# of Institutions
157Shares Held
107MCall Options Held
65KPut Options Held
1.2M-
Ra Capital Management, L.P. Boston, MA14.2MShares$141 Million1.71% of portfolio
-
Janus Henderson Group PLC London, X013.3MShares$132 Million0.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.03MShares$80.1 Million2.69% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$73.6 Million0.99% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$69.9 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $463M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...